Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

Clinical trial NCT00033072 · UNKNOWN

Trial details

NCT number: NCT00033072
Sponsor: National Institute on Drug Abuse (NIDA)
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Amphetamine-Related Disorders

Start date: 2001-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.